What is the ROE (Return on Equity) of Conmed this year?
The ROE of Conmed this year is 0.08 undefined.
Conmed ROE 2025
Conmed ROE
0.08
Ticker
CNMD
ISIN
US2074101013
WKN
886793
In 2025, Conmed's return on equity (ROE) was 0.08, a -171.47% increase from the -0.11 ROE in the previous year.
Conmed Aktienanalyse
What does Conmed do?
Conmed Corporation is a leading medical technology company that offers a wide range of surgical instruments and devices for the fields of gastroenterology, endoscopy, orthopedics, gynecology, and electro surgery. The company was founded in 1970 and is headquartered in Utica, New York. The history of Conmed Corp began with the founding of Consolidated Medical Equipment, Inc. (CME) in 1970. The company initially started its business with the distribution of surgical instruments and devices for medical applications and quickly expanded in this field. In the 1980s, the company went public. In the 1990s, the company changed its name to Conmed Corporation and expanded its activities into the field of electro surgery, which has since become a major growth driver for the company. Today, Conmed Corp operates multiple manufacturing facilities worldwide and has sales offices in over 50 countries. The company is divided into four main business segments: gastroenterology, endoscopy, orthopedics, and electro surgery. The gastroenterology segment includes products for the diagnosis and treatment of gastrointestinal disorders, such as endoscopes, biopsy instruments, dilation balloons, trocars, and shears. In the endoscopy segment, Conmed Corp offers products for the diagnosis and treatment of digestive tract disorders, including endoscopes, biopsy instruments, dilation balloons, trocars, and shears. The orthopedics segment includes a wide range of surgical instruments and devices for the treatment of musculoskeletal disorders, including implants, bandages, bone plates, intramedullary nails, and others. Finally, the electro surgery segment is the fastest-growing segment of Conmed Corp and includes a wide range of devices for precision surgery, including electrocautery, electro surgery, endoscopy, and laparoscopy devices. Conmed Corp aims to develop innovative medical technologies that meet the needs of patients and healthcare professionals. The company places great emphasis on producing high-quality products that are reliable and safe. Conmed Corp is a successful company that continues to evolve and expand its product range to meet the rapidly evolving needs of the medical community. Conmed ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Conmed's Return on Equity (ROE)
Conmed's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Conmed's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Conmed's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Conmed’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Conmed stock
How has the Return on Equity (ROE) of Conmed developed compared to the previous year?
The ROE of Conmed has increased by -171.47% decreased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Conmed?
A high ROE indicates that Conmed generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Conmed?
A low ROE can indicate that Conmed is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Conmed affect the company?
A change in ROE (Return on Equity) of Conmed can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Conmed?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Conmed?
Some factors that can influence Conmed's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Conmed pay?
Over the past 12 months, Conmed paid a dividend of 0.8 USD . This corresponds to a dividend yield of about 1.17 %. For the coming 12 months, Conmed is expected to pay a dividend of 0.82 USD.
What is the dividend yield of Conmed?
The current dividend yield of Conmed is 1.17 %.
When does Conmed pay dividends?
Conmed pays a quarterly dividend. This is distributed in the months of April, July, October, January.
How secure is the dividend of Conmed?
Conmed paid dividends every year for the past 16 years.
What is the dividend of Conmed?
For the upcoming 12 months, dividends amounting to 0.82 USD are expected. This corresponds to a dividend yield of 1.2 %.
In which sector is Conmed located?
Conmed is assigned to the 'Health' sector.
Wann musste ich die Aktien von Conmed kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Conmed from 1/3/2025 amounting to 0.2 USD, you needed to have the stock in your portfolio before the ex-date on 12/20/2024.
When did Conmed pay the last dividend?
The last dividend was paid out on 1/3/2025.
What was the dividend of Conmed in the year 2024?
In the year 2024, Conmed distributed 0.8 USD as dividends.
In which currency does Conmed pay out the dividend?
The dividends of Conmed are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Conmed
Our stock analysis for Conmed Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Conmed Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
